Skip to main content

Table 1 Patient and tophus characteristics at the time of surgerya

From: Bone destruction by receptor activator of nuclear factor κB ligand-expressing T cells in chronic gouty arthritis

Patient characteristics (n = 8)  
   No. (%) male 7 (88)
   Age, median (range) years 46 (31 to 67)
Duration of gout, median (range) years 12 (4 to 30)
No. (%) prescribed allopurinol 6 (75)
No. (%) prescribed colchicine 7 (87.5)
No. (%) prescribed nonsteroidal anti-inflammatory drugs 2 (25)
   Serum urate, median (range) mg/dl 6.6 (5 to 9.8)
   CRP, median (range) mg/dl 0.84 (0.2 to 4.3)
Tophus characteristics (n = 14)  
   Duration of tophus, median (range) years 5 (1.5 to 7)
Location of tophus  
   First MTP joint, No. (%) 7 (50)
   Ankle joint, No. (%) 4 (29)
   Elbow joint, No. (%) 2 (14)
   Hand PIP joint, No. (%) 1 (7)
Indication for surgery  
   Mechanical problem, No. (%) 10 (71)
   Pain control, No. (%) 4 (28)
Sepsis control (infected/ulcerated tophi), No. (%) 0 (0)
  1. CRP, C-reactive protein; MTP, metatarsophalangeal; No., number; PIP, proximal interphalangeal. aData are presented as medians and ranges or percentages.